QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 4. Mapping and mutation of Exu phosphorylation sites. (A) Position of the two potential 14-3-3 binding sites (red) in Exu protein (grey bar). Sequences of site A (amino acids 434-440) and B (amino acids 453-459) and of the corresponding mutations (A1-A6 and B1-B3) are shown below. (B-D) Autoradiographic images of SDS polyacrylamide gels showing in vitro translated and radiolabelled wild-type or mutant Exu proteins after incubation with Par-1. Mutations in site A and B are indicated above the lane. (E) Western blot of ovarian extracts probed with an antibody against Exu (upper panel) or Tubulin (lower panel) as a loading control. Exu protein was expressed from transgenes using the endogenous exu promoter in an exu-null background (exu^XL/exu^VL). Transgenes encode either wild-type or mutant Exu protein. The nature of the mutation is indicated above the corresponding lane. The first lane shows extracts from exu null mutant ovaries expressing Exu-GFP protein, in which all Par-1 phosphorylation sites are mutated (GFP A6B3). This mutant protein runs in a single band, indicating absence of phosphorylation. The second lane shows extracts from wild-type ovaries expressing Exu-GFP. Exu-GFP is phosphorylated and migrates as a triplet around 100 kDa while untagged Exu migrates around 66 kDa.

Return to article